Latest 24 News in the Life Sciences Industry

Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

By: PR Newswire Association LLC. - 16 Jul 2025

ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO

By: PR Newswire Association LLC. - 16 Jul 2025

Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors

By: PR Newswire Association LLC. - 16 Jul 2025

PHASE Scientific Expands INDICAID® Respiratory Portfolio with Exclusive U.S. Launch of Novel FebriDx® Test

By: PR Newswire Association LLC. - 16 Jul 2025

Acumen Pharmaceuticals and JCR Pharmaceuticals Enter Strategic Collaboration, Option and License Agreement to Develop Enhanced Brain Delivery™ Therapy for Alzheimer’s Disease

By: GlobeNewswire - 15 Jul 2025

Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025

By: GlobeNewswire - 15 Jul 2025

Encompass Health Rehabilitation Hospital of Daytona Beach now open in Florida

By: PR Newswire Association LLC. - 15 Jul 2025

Adaptive Biotechnologies to Report Second Quarter 2025 Financial Results on August 5, 2025

By: GlobeNewswire - 15 Jul 2025

Palatin Announces Positive Preclinical Efficacy Data for Oral MC4R Agonist PL7737 in Animal Model of Obesity

By: PR Newswire Association LLC. - 15 Jul 2025

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

By: GlobeNewswire - 15 Jul 2025

Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results

By: GlobeNewswire - 15 Jul 2025

Tract Bio Appoints Chris Galloway, M.D., as Chief Medical and Development Officer and Expands Board of Directors

By: PR Newswire Association LLC. - 15 Jul 2025

Bill To Create Secret Doctor Drug Treatment Program Will Not Move Forward This Year, Says Consumer Watchdog

By: PR Newswire Association LLC. - 15 Jul 2025

Ikena Oncology Announces Stockholder Approval of Merger with Inmagene Biopharmaceuticals

By: GlobeNewswire - 15 Jul 2025

Tivity Health Appoints Natasha Deckmann as CEO

By: GlobeNewswire - 15 Jul 2025

Echosens and United Digestive Partner to Expand Access to Non-Invasive Liver Diagnostics

By: PR Newswire Association LLC. - 15 Jul 2025

Merakris Therapeutics Selected as Finalist for 2025 Advanced Wound Care Summit Innovation Showcase

By: GlobeNewswire - 15 Jul 2025

AUA Says Legislation Critical to Saving Private Practice Medicare Providers

By: PR Newswire Association LLC. - 15 Jul 2025

Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection

By: PR Newswire Association LLC. - 15 Jul 2025

Uniti Med Recognized as a BluePipes "Best Travel Nursing Company" for Third Consecutive Year

By: PR Newswire Association LLC. - 15 Jul 2025

trū® Chitosan Files Patent on New USP Inhalant Product

By: PR Newswire Association LLC. - 15 Jul 2025

Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025

By: GlobeNewswire - 15 Jul 2025

2026 Medicare Physician Fee Schedule Rates Set for Scalp Cooling CPT Codes

By: PR Newswire Association LLC. - 15 Jul 2025

Lung Scan Technology Reveals Hidden Secrets of Airway Disease

By: PR Newswire Association LLC. - 15 Jul 2025

Looking for more life science news?

Browse Biotechgate for global news, company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

August 2025
- Biotechgate Digital Partnering August 2025
September 2025
- Boston: LSX USA Congress
October 2025
- Amsterdam: World Orphan Drug Congress Europe 2025

See Events »

Add an Event »

Latest company news

Akeso Announces First Patient Enrolled in the Phase III Trial（AK112-312/HARMONi-GI6）of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer
16 Jul 2025 (PR Newswire Association LLC.)

ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by WHO
16 Jul 2025 (PR Newswire Association LLC.)

Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors
16 Jul 2025 (PR Newswire Association LLC.)